Acasti Announces Alignment with FDA on GTX-104 Pivotal Phase 3 Safety Trial Protocol and Confirms Planned Initiation of STRIVE-ON in aSAH Patients in Calendar Q4 2023 July 5, 2023
The Glimpse Group Announces Augmented Reality Books Partnership between Post Reality and Educational Publishing Company Lightswitch Learning March 22, 2022